Literature DB >> 2873315

Is Clostridium difficile endemic in chronic-care facilities?

B S Bender, R Bennett, B E Laughon, W B Greenough, C Gaydos, S D Sears, M S Forman, J G Bartlett.   

Abstract

An apparent outbreak of Clostridium difficile diarrhoea on the chronic hospital ward of a long-term care facility prompted an investigation lasting seven months. Approximately a third of patients had stools that were positive for C difficile by either toxin or culture. Attempts to eradicate the infection by simultaneously treating all toxin-positive patients with metronidazole, limiting antibiotic use, and implementing enteric isolation were unsuccessful. New cases were both nosocomially acquired and imported into the facility. Of the C difficile toxin-positive patients, 34% had diarrhoea and 19/49 (38%) died during the study period. C difficile is not routinely sought by most clinical microbiology laboratories and may therefore be endemic in many long-term care facilities for the elderly.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873315     DOI: 10.1016/s0140-6736(86)92559-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  39 in total

Review 1.  Clostridium difficile associated diarrhoea: diagnosis and treatment.

Authors:  John Starr
Journal:  BMJ       Date:  2005-09-03

2.  A cost-effectiveness study of the management of intractable urinary incontinence by urinary catheterisation or incontinence pads.

Authors:  M E McMurdo; P G Davey; M A Elder; R M Miller; D C Old; M Malek
Journal:  J Epidemiol Community Health       Date:  1992-06       Impact factor: 3.710

3.  Transmission modes and the evolution of virulence : With special reference to cholera, influenza, and AIDS.

Authors:  P W Ewald
Journal:  Hum Nat       Date:  1991-03

4.  Application of whole-cell DNA restriction endonuclease profiles to the epidemiology of Clostridium difficile-induced diarrhea.

Authors:  E J Kuijper; J H Oudbier; W N Stuifbergen; A Jansz; H C Zanen
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

5.  Clostridium difficile in neonates: serogrouping and epidemiology.

Authors:  M Delmée; G Verellen; V Avesani; G Francois
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

6.  Somatosensory evoked potentials and outcome in perinatal asphyxia.

Authors:  N A Gibson; M Graham; M I Levene
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

7.  Detection of Clostridium difficile toxin by enzyme immunoassay, tissue culture test and culture.

Authors:  O Liesenfeld; F Saeger; H Hahn
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

8.  Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.

Authors:  J F Torres; D M Lyerly; J E Hill; T P Monath
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project.

Authors:  M Hyland; M Ofner-Agostini; M Miller; S Paton; M Gourdeau; M Ishak
Journal:  Can J Infect Dis       Date:  2001-03

Review 10.  The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.

Authors:  M Andréjak; J L Schmit; A Tondriaux
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.